Navigation Links
Oramed Pharmaceuticals Chosen to Present Oral Insulin Trial Results at EASD Conference (September 7-11, Rome)
Date:8/18/2008

JERUSALEM, Israel, August 18 /PRNewswire-FirstCall/ -- Oramed Pharmaceuticals, Inc. (OTCBB: ORMP.OB) (http://www.oramed.com), a developer of oral delivery systems, announced today that its abstract, entitled "Open Label Study to Assess the Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Five Oral Insulin Formulations in Healthy Subjects," has been chosen for presentation at the upcoming 44th Annual Meeting of the European Association for the Study of Diabetes (EASD) in Rome, highlighting the successful results from its oral insulin trials on healthy volunteers.

Oramed's poster has been assigned presentation number PS 093 New Treatments and is available for viewing throughout the conference. Oramed's Chief Scientific Officer, Dr. Miriam Kidron, and Dr. Ehud Arbit, Oramed's Director of Research and Development, will present the poster on Tuesday Sept. 9, 2008, from 12:30 p.m. to 1:30 p.m.

"The fact that Oramed has been selected to present research at the EASD Conference underscores the importance of our work developing an oral insulin capsule," said Nadav Kidron, Oramed CEO. "We look forward to sharing the results of our Phase 1B trials with top diabetes researchers from around the world."

For more information about the EASD and the upcoming conference, please visit http://www.easd.org.

About Oramed Pharmaceuticals

Oramed Pharmaceuticals is a technology pioneer in the field of oral delivery solutions for drugs and vaccines presently delivered via injection. Oramed is seeking to revolutionize the treatment of diabetes through its patented flagship product, an orally ingestible insulin capsule currently in phase 2 clinical trials. Established in 2006, Oramed's technology is based on over 25 years of research by top research scientists at Jerusalem's Hadassah Medical Center. The Company's corporate and R&D headquarters are
'/>"/>

SOURCE Oramed Pharmaceuticals Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Oramed Pharmaceuticals Announces Successful Phase 2A Clinical Trial of its Oral Insulin Capsule
2. Oramed Pharmaceuticals to Hold Conference Call on August 6 to Present Results of Phase 2A Oral Insulin Capsule Clinical Trials
3. Peregrine Pharmaceuticals Doses First Patient in Phase II Trial of Bavituximab in Patients With Advanced Breast Cancer
4. Rib-X Pharmaceuticals, Inc. Announces Recent and Upcoming Presentations at Scientific Conferences
5. Quark Pharmaceuticals Announces First Patient Dosing by Pfizer in Phase II Trial of RNAi Therapy in Diabetic Macular Edema
6. Idenix Pharmaceuticals Advances HCV Discovery Program to Clinic
7. Celator Pharmaceuticals Raises Series C Financing in Excess of $22.5 Million
8. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Second Quarter 2008 Financial Results and Provide a Clinical Program Update on August 7, 2008
9. Sound Pharmaceuticals Files Second IND with the FDA for the Prevention of Chemotherapy Induced Hearing Loss in Advanced Stage Cancer
10. Meditrina Pharmaceuticals, Inc. Opens Investigational New Drug (IND) Application for Phase IIb Clinical Trial With MPI-676 in Endometriosis
11. BioNumerik Pharmaceuticals Observes Evidence of a Survival Increase in Lung Cancer Patients Participating in Tavocept(TM) Clinical Trial

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...M, N.C., Nov. 6 Oxygen B...day announced that a previously approved reverse s...tart of trading on Monday, Nov. 9, 2009 on a 1-for...Inc. shares will trade under the new symbol OXBT. ...P 20 9, when the split becomes effective. ,, "T...
(Date:11/6/2009)..., FORT WASHINGTON, Pa., Nov. 6 ...stration (FDA), McNeil Consumer Healthcare, Divisi...recall of a limited number of product lots of TYLE... with the distinctive red EZ-OPEN CAP. McNeil is i...teristic smell or taste associated with these lots...
(Date:11/6/2009)...IEGO, Nov. 6 Trius Therapeutics, I...on statement on Form S-1 with the U.S. Securities ...ed initial public offering of shares of its common...in the offering will be offered by the Company. ,...s sole book-running manager, Piper Jaffray & C...
Breaking Medicine Technology:Oxygen Biotherapeutics, Inc. Announces 1:15 Reverse Stock Split to Take Effect Nov. 9, 2009 2Oxygen Biotherapeutics, Inc. Announces 1:15 Reverse Stock Split to Take Effect Nov. 9, 2009 3McNeil Consumer Healthcare Announces Voluntary Recall of Certain Lots of TYLENOL(R) Arthritis Pain 100 Count with EZ-OPEN CAP 2Health Enhancement Products Reacquires ProAlgaZyme 28TM 29 Distribution and Marketing Rights 58753 1Health Enhancement Products Reacquires ProAlgaZyme 28TM 29 Distribution and Marketing Rights 58753 2American Lung Association of Florida South Area Encourages Miami Residents to See Themselves Among the Many Faces of Influenza 58749 1American Lung Association of Florida South Area Encourages Miami Residents to See Themselves Among the Many Faces of Influenza 58749 2American Lung Association of Florida South Area Encourages Miami Residents to See Themselves Among the Many Faces of Influenza 58749 3American Lung Association of Florida South Area Encourages Miami Residents to See Themselves Among the Many Faces of Influenza 58749 4American Lung Association of Florida South Area Encourages Miami Residents to See Themselves Among the Many Faces of Influenza 58749 5R 26amp 3BD Leverage Heightens Investment in Medical and Silicone Mold Manufacturing 58745 1R 26amp 3BD Leverage Heightens Investment in Medical and Silicone Mold Manufacturing 58745 2R 26amp 3BD Leverage Heightens Investment in Medical and Silicone Mold Manufacturing 58745 3
(Date:11/9/2009)... , SAN DIEGO, Nov. 9 , , W...ree pet nutrition, workshop facilitat... experts on Saturday, November 14 at 2 p.m. ...parents will learn about the nutritional needs of,...o discuss the benefits of, good pet n...
(Date:11/9/2009)... , St. Jude Children,s Research Hospital and the ...e formed a collaboration to provide proton therapy...he approval of the first clinical study to evaluat... in children younger than 3 years old. , Under...ts to receive proton therapy at the UF Proton Ther...
(Date:11/9/2009)... , Arnhem, November 2009 The December issue of ...opean Association of Urology, features an article ...ile Men? Results of a Prospective Case-Control Sur...s that male factor infertility is associated with ...scored with the hospital-based Charlson Comorbidit...
(Date:11/9/2009)... , , Blacksburg, Va. In the construction industr...y or an increased risk of cancer, is a major publi...rbett, a faculty member in Virginia Tech,s School ... sanding tools are highly effective in reducing th...ndustry,s usage of the available technology remain...
(Date:11/9/2009)... , Irvine, Calif., Nov. 9, 2009 The first human ...for human testing has been shown to restore limb f...finding that could expand the clinical trial to in... the U.S. Food & Drug Administration gave Geron Co...UC Irvine treatment in individuals with thoracic s...
Breaking Medicine News(10 mins):Health News:St. Jude and UF Proton Therapy Institute to begin proton therapy clinical trial 2Health News:European Urology: Male factor infertility associated with comorbidities 2Health News:Dust control research leads to a NIOSH grant to facilitate adoption of hazard controls 2Health News:Dust control research leads to a NIOSH grant to facilitate adoption of hazard controls 3Health News:UCI embryonic stem cell therapy restores walking ability in rats with neck injuries 2
...ers at the University of Edinburgh have shown that... patients, giving women a new hope. The stud...s proved for the first time that the targeted use ... hormone therapy already used with great success ...
...rado Springs community of U.S is waiting with bate... see if any person has contracted TB from a young...ording to health officials, tuberculosis has been ...o Dr. Ned Calonge, chief medical officer for the C...
...ardly surprising when a Dutch TV network decided t...nth and air a TV reality show featuring a dying wo...e to China, tens of thousands of kidney sufferers ...nsplants, and even in wealthier Europe, 10 deaths ...
...d cigarette packets, McDonald's wrappers and even ...g Kong's far north, home to what remains of the te...e border in China, factories belch smoke into the ...llution is one of the biggest problems facing the ...
...ers at the La Jolla Institute for Allergy & Immuno... eventually lead to a new therapeutic approach for...ch as rheumatoid arthritis, colitis, psoriasis and... the body, in regulating inflammation. In the...
... be spending $33 million to add about 200 mental h...umatic stress disorder and other mental health nee...sychological effects of war have increased," conce...time military is not adequate for a nation that's ...
Other Medicine News:Health News:Hormone Therapy An Alternative to Chemotherapy for Ovarian Cancer 2Health News:Fears Of Spread Of TB After Students Death 2Health News:The Long Wait ... Dying for Lack of Kidneys 2Health News:The Long Wait ... Dying for Lack of Kidneys 3Health News:The Long Wait ... Dying for Lack of Kidneys 4Health News:Hong Kong Choked by Growing Pollution Problem 2Health News:Hong Kong Choked by Growing Pollution Problem 3Health News:New Therapeutic Approach for Autoimmune and Inflammatory Diseases 2Health News:US Army to Recruit More Psychiatrists to Counsel Stressed Out Soldiers 2Health News:US Army to Recruit More Psychiatrists to Counsel Stressed Out Soldiers 3
Hemaway Original®
...o-use, pre-cleaning enzymatic foam for use on meta... sprays on surgical instruments to pre-clean and p... or when cleaning is not immediately available. Ge... reduce scrubbing time later and protect your surg...
... and non-silicone lubricant formulated for use in ...oves blood and organic materials while lubricating...rated, low-foaming Duo-Klenz removes blood and org...nstruments -- all in one easy step! Duo-Klenz is f...
...patients finger snugly. Wrap the patients finger w... Finger Trap for an extra secure fit without skin ...complete upper extremity traction system when used...K Table. Stainless Steel Finger Traps come in four...
Medicine Products: